Skip to main content
GameRevenueData

Publisher

Games Published by Dream Stories: Revenue & Sales Estimates

Revenue estimates for the 14 Steam games published by Dream Stories, ranked by estimated net revenue. Available estimated lifetime net (USD): $5.9K.

Catalog Est. Lifetime Net (USD)

$5.9K

Estimates for 1 of 14 tracked games

Tracked games

14

Top Earner

Kamigami: Clash of the Gods

$5.9K

Coverage: 14 tracked titles; 1 with net estimates; 13 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.

Role: Publisher. These are lifetime estimates for games credited to Dream Stories; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.

Recorded release dates: 2022-07-24–2025-07-18 (may include announced dates).

Largest title accounts for 100.0% of available estimated net revenue. Coverage gaps can change this share.

Showing 1–14 of the top 14 displayed entries, from 14 tracked titles. Figures include only available estimates. Search the full catalog .

Rows 1–14 · Page 1 of 1

# Game Est. lifetime net (USD) Positive reviews (raw) Release
1 Kamigami: Clash of the Gods $5.9K 92%Positive (24) Jul 24, 2022
2 AlphaBlue (0)
3 Valledi 100%Positive (3) Dec 13, 2024
4 Kamigami: Spirits of the Nature (0)
5 Envyus 86%Positive (7) Nov 13, 2024
6 Mikene's Aspects (0)
7 Vorum (0)
8 Elowyn and the Stolen Souls (0)
9 Apu's Journey (0)
10 Love Criminals (0)
11 Astral Wield 100%Positive (8) Jul 18, 2025
12 Ashley: The One-Spell Mage (0)
13 Sur: Wheelchair Horror (0)
14 Thalia (0)

Get real-time dashboards, historical trends, and AI-powered analysis

Explore on PlayRev(opens in new tab)

Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.